Keytruda (Pembrolizumab)
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for Keytruda (Pembrolizumab), covering 2017-11-24 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma [Phase 2]